Holen Sie sich die Stockscreener-App
0.9001
8.76%
-0.0864
Handel nachbörslich:
.87
-0.0301
-3.34%
Schlusskurs vom Vortag:
$0.9865
Offen:
$0.9246
24-Stunden-Volumen:
2.13M
Relative Volume:
0.34
Marktkapitalisierung:
$29.42M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-563.30K
KGV:
-4.5095
EPS:
-0.1996
Netto-Cashflow:
$-22.23M
1W Leistung:
-19.63%
1M Leistung:
+87.44%
6M Leistung:
+1.83%
1J Leistung:
-43.74%
1-Tages-Spanne:
$0.86
$0.9401
1-Wochen-Bereich:
$0.77
$1.06
52-Wochen-Spanne:
$0.38
$1.75
Promis Neurosciences Inc Stock (PMN) Company Profile
Firmenname
Promis Neurosciences Inc
Sektor
Branche
Telefon
416-847-6898
Adresse
SUITE 200, 1920 YONGE STREET, TORONTO
Vergleichen Sie PMN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PMN
Promis Neurosciences Inc
|
0.9001 | 32.25M | 0 | -563.30K | -22.23M | -0.1996 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Promis Neurosciences Inc Aktie (PMN) Neueste Nachrichten
When is ProMIS Neurosciences Inc. stock expected to show significant growthPre Market Entry Points To Watch Now - jammulinksnews.com
ProMIS Neurosciences Inc (PMN) Stock: A Year of Highs and Lows in the Market - investchronicle.com
ProMIS Neurosciences Announces Private Placement Financing - The Manila Times
ProMIS Neurosciences raises $12 million through PIPE financing and warrants - Investing.com Australia
Intrinsic Value of ProMIS Neurosciences Inc. Stock: Is It Undervalued or OvervaluedPrice Forecast Based on AI Analysis - Newser
Building trade automation scripts for ProMIS Neurosciences Inc.Predictive Analytics for Equity Growth Potential - Newser
What is the risk reward ratio of investing in ProMIS Neurosciences Inc. stockAchieve rapid wealth accumulation with smart picks - jammulinksnews.com
Clinical-Stage Biotech ProMIS Raises $12M to Advance Novel Alzheimer's Treatment PMN310 - Stock Titan
Multi factor analysis applied to ProMIS Neurosciences Inc.Chart Risk Profile for Capital Preservation - Newser
What makes ProMIS Neurosciences Inc. stock price move sharplyAI Stock Movement Forecast with Accuracy - Newser
What earnings revisions data tells us about ProMIS Neurosciences Inc. Free Buy Low Sell High Stock Watch - Newser
How strong is ProMIS Neurosciences Inc. company’s balance sheetMaximize gains with strategic stock entries - jammulinksnews.com
Is it the right time to buy ProMIS Neurosciences Inc. stockMaximize your gains with expert trading tips - jammulinksnews.com
Sectors Driving Future Growth for ProMIS Neurosciences Inc. StockDaily Gain Forecast - Newser
How Efficient Is ProMIS Neurosciences Inc. at Controlling Operating CostsSafe and Smart Investment Picks - Newser
Should I buy ProMIS Neurosciences Inc. stock before earningsWatchlist Winner Update - Newser
How many analysts rate ProMIS Neurosciences Inc. as a “Buy”Get timely market insights for better trades - jammulinksnews.com
What drives ProMIS Neurosciences Inc. stock priceMassive portfolio appreciation - PrintWeekIndia
Analysts Are Bullish on Top Healthcare Stocks: ProMIS Neurosciences (PMN), Bruker (BRKR) - The Globe and Mail
ProMIS Neurosciences Alights on Path to Novel Alzheimer’s Treatment - StocksToTrade
Is ProMIS Neurosciences Inc. stock a growth or value playFree Predictions - jammulinksnews.com
ProMIS Neurosciences Inc. Stock Analysis and ForecastExplosive earnings growth - Autocar Professional
What analysts say about ProMIS Neurosciences Inc. stockAccelerated earnings growth - PrintWeekIndia
When is the best time to buy ProMIS Neurosciences Inc. stockHigh-impact stock picks - jammulinksnews.com
Will ProMIS Neurosciences Inc. stock split in the near futureConsistent triple-digit returns - jammulinksnews.com
ProMIS Neurosciences Announces $3.2M Fundraising Initiatives - The Globe and Mail
ProMIS Neurosciences Gains FDA Fast Track for PMN310 - The Globe and Mail
Is ProMIS Neurosciences Inc. a good long term investmentHigh-yield market plays - jammulinksnews.com
Earnings Misses And Clinical Hurdles Rattle Major Stocks - Finimize
Still undervalued? ProMIS Neurosciences keeps $9.50 target price at Leede - Cantech Letter
Alzheimer’s stock triples after FDA Fast-Track Designation - MSN
ProMIS Neurosciences Plunges 24.56% Intraday—Is the FDA Fast Track Outpacing Investor Sentiment? - AInvest
ProMIS Neurosciences Plunges 28% Intraday—Is This the Catalyst No One Saw Coming? - AInvest
Buy Rating for ProMIS Neurosciences Driven by Fast Track Designation and Promising Alzheimer’s Treatment Potential - TipRanks
ProMIS Neurosciences announces $0.8M registered direct offering - TipRanks
ProMIS Neurosciences announces private placement financing - TipRanks
Finanzdaten der Promis Neurosciences Inc-Aktie (PMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):